blinatumomab – Patient Worthy

192635 / Pixabay

Blinatumomab Immunotherapy is Effective for Infants with Aggressive Acute Lymphoblastic Leukemia (ALL)

Post author:Jessica Lynn
Post published:May 8, 2023
Post category:Acute lymphoblastic leukemia

KMT2A rearrangements—a DNA fault—lead to treatment-resistant acute lymphoblastic leukemia (ALL) in infants. While around 50% of children with KMT2A rearrangements respond well to intensive chemotherapy, the remaining 50% do…

CLICK HERE TO SHARE YOUR STORY!

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Keep Up to Date

Learn More